NIAID has issued a new request for applications (RFA) to establish a leadership group responsible for a new clinical research network focused on antibacterial resistance. The leadership group will have overall responsibility for designing, prioritizing, implementing, and managing the network's clinical research agenda to address antibacterial resistance-related scientific priorities.
The new RFA is one of several expected from NIAID this year as it works to revamp its existing HIV/AIDS clinical trials networks. Applications for the antibacterial resistance leadership group RFA are due by June 1, 2012. Awards are expected to be made in 2013.
To view the RFA, go to: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-019.html. For the latest information on NIAID's clinical trials network restructuring process, see http://www.niaid.nih.gov/labsandresources/restructuring/Pages/default.aspx. And for more information about NIAID's antimicrobial (drug) resistance research, view: http://www.niaid.nih.gov/topics/antimicrobialresistance/Pages/default.aspx.
.png)
No hay comentarios:
Publicar un comentario